Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TER vs MRNA✓SelectedUSD · MRNATER vs MRNA performance historyLatest closeAs of+0.98%11/17
Stock and ETF performance explorer

TER vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+57.4%
MRNA return
-11.9%
Excess return
+69.4%
Maximum drawdown
-59.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.0%-3.9%+4.9%+1.3%
7D-4.6%-17.6%+13.0%-3.1%
30D-27.9%-5.1%-22.8%-27.6%
3M-47.1%+220.8%-268.0%-55.4%
6M-30.6%+321.7%-352.3%-46.6%
YTD+21.1%+601.3%-580.1%-19.7%
1Y+40.1%+735.2%-695.1%-11.6%
3Y+157.1%+170.5%-13.5%+98.2%
5Y+57.4%-14.6%+72.1%+37.6%
All+57.4%-11.9%+69.4%+37.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling